SYSTEMIC EFFECTS OF TOPICAL APPLICATION OF BECLOMETHASONE 17,21‐DIPROPIONATE—COMPARATIVE STUDIES WITH BETAMETHASONE 17‐VALERATE OINTMENT AND FLUOCINONIDE CREAM—

By  

THE JOURNAL OF DERMATOLOGY, Vol. 6, Iss. 6, 1979-12 ,pp. : 383-390

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real‐life effectiveness of once‐daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52‐week PRO‐long study

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 12, 2015-12 ,pp. : 2349-2355

John Wiley & Sons Inc

Access to resources Recommend Favorite

The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis – an introduction

By Freeman Keith  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 197-203

Informa Healthcare

Access to resources Recommend Favorite

Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland

By Affleck Andrew G.   Bottomley Julia M.   Auland Merran   Jackson Peter   Ryttov Jacob  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 269-284

Informa Healthcare

Access to resources Recommend Favorite

Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris

By van de Kerkhof Peter   de Peuter Ria   Ryttov Jacob   Jansen Jeroen P.  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 225-238

Informa Healthcare

Access to resources Recommend Favorite